Ziyad Al-Aly: GLP-1 Cuts Addiction Risk but Weight Regain Follows

A study led by Ziyad Al-Aly involving 600,000 veterans shows that GLP-1 medications reduce the risk of developing addictions to alcohol and opioids by 25%.For patients with existing substance use disorders, the treatment was linked to a 50% decrease in drug-related deaths as noted by Joar Guterstam.However, research led by Brajan Budini reveals that patients typically regain an average of 60% of their lost weight within one year of stopping use.While GLP-1 drugs like Ozempic show promise for addiction medicine, experts await clinical trials before recommending them for substance dependence.